182
IMMUNITY THE ABILITY TO RESIST DISEASE

IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC /toc.htm

Embed Size (px)

Citation preview

Page 1: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNITY

THE ABILITY TO RESIST DISEASE

Page 2: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NONSPECIFIC VS SPECIFIC

http://www.microbiologytext.com/

http://www.gsbs.utmb.edu/microbook/toc.htm

Page 3: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NONSPECIFIC

• PHYSICAL BARRIERS

• CHEMICAL BARRIERS

• CELLULAR BARRIERS

• INFLAMMATION

• FEVER

Page 4: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SPECIFIC IMMUNITY

• IMMUNE CELLS RECOGNIZE FOREIGN ANTIGENS

• DIRECTLY OR INDIRECTLY ELIMINATE THEM

Page 5: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ACQUIRED IMMUNITY

NATURAL VS ARTIFICIAL

ACTIVE VS PASSIVE

Page 6: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NATURALLY ACQUIRED ACTIVE IMMUNITY

• DUE TO ANTIGENIC STIMULUS FROM INFECTION

• ANTIBODIES

• SENSITIZED LYMPHOCYTES

• SHORT TERM TO LONG TERM

• MEMORY CELLS MADE

Page 7: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NATURALLY ACQUIRED PASSIVE IMMUNITY

• ANTIBODIES TRANSFERRED FROM MOTHER TO INFANT

• ACROSS THE PLACENTA– Ig G– SHORT TERM IMMUNITY

• IN THE CLOSTRUM AND MILK– IgA– AS LONG AS BABY IS NURSING

• NO MEMORY CELLS ARE FORMED

Page 8: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ARTIFICIALLY ACQUIRED ACTIVE IMMUNITY

• VACCINATIONS/IMMUNIZATION– KILLED OR WEAKENED MICROBES– INACTIVATED TOXINS– COMPONENTS OF CAPSIDS, CAPSULES

OR OTHER MICROBIAL COMPONENTS– VECTOR VACCINES

• MEMORY CELLS ARE FORMED

Page 9: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ARTIFICIALLY ACQUIRED PASSIVE IMMUNITY

• TRANSFER OF ANTIBODIES FROM SOME OTHER ORGANISM

• SHORT TERM IMMUNITY

• NO MEMORY CELLS FORMED

Page 10: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIGENS

• ANTIBODY GENERATING MOLECULES

• IMMUNOGENS/ALLERGENS

• SELF VS NONSELF

• MARKERS ON CELLS, PROTEINS, VIRUSES AND ETC

Page 11: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CHARACTERISTICS OF ANTIGENS

• LARGE

• COMPLEX

• PROTEINS

• NUCLEOPROTEINS

• POLYSACCHARIDES

• GLYCOLIPIDS

Page 12: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIGENIC DETERMINANT SITES

• SITES ON ANTIGEN THAT CAUSE PRODUCTION OF ANTIBODY

• MONOVALENT

• MULTIVALENT

• HETEROPHILE OR HETEROLOGOUS

Page 13: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

HAPTENS

• SMALL ORGANIC MOLECULES

• NOT ANTIGENIC BY ITSELF

• MUST BIND TO CARRIER MOLECULE

• PENICILLIN

• NICKEL

Page 14: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CELLS OF THE SPECIFIC IMMUNE RESPONSE

LYMPHOCYTES

Page 15: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

LYMPHOCYTE FUNCTION

B CELL

Page 16: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

B CELLS

• MADE IMMUNOCOMPETENT IN FETAL LIVER AND BONE MARROW

Page 17: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

PLASMA CELLS

• DERIVED FROM B CELLS

• RESPOND TO ANTIGEN BY SECRETING ANTIBODIES

• HUMORAL DEFENSE

• DEFEND AGAINST BACTERIA, BACTERIAL TOXINS AND VIRUSES FOUND IN BODY TISSUES

Page 18: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

PLASMA CELL

Page 19: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODIES

• GLYCOPROTEINS

• GAMMA GLOBULIN PORTION OF SERUM

• DIFFER IN MOLECULAR SIZE, STRUCTURE, CHARGE, AMINO ACID COMPOSITION AND CARBOHYDRATE COMPOSITION

• FIVE CLASSES

Page 20: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULINS

• IgA

• IgD

• IgE

• IgG

• IgM

Page 21: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CHARACTERISTICS OF ANTIBODIES

• MOST ARE BIVALENT

• CRYSTALIZABLE FRAGMENT (Fc)

• ANTIBODY BINDING FRAGMENT (Fab)

• FOUR POLYPEPTIDE BONDS

• LIGHT AND HEAVY CHAINS

• HEAVY CHAINS DETERMINE CLASS

• FLEXIBLE HINGE REGION

Page 22: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

STRUCTURE OF ANTIBODY MOLECULE

Page 23: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODY SUBCLASSES

• Ig A

• Ig G

Page 24: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FUNCTION OF IMMUNOGLOBULINS

• ALL ARE BIFUNCTIONAL• Fab BINDS TO ANTIGEN• Fc BINDS TO COMPLENT AND CELLS• DOES NOT LEAD TO DIRECT

DESTRUCTION• MARKS CELL FOR DESTRUCTION• ACTIVATES NONSPECIFIC RESPONSES

Page 25: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULIN CLASSES

Page 26: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULIN G

• MAJOR Ig IN SERUM

• 70-75 % OF IMMUNOGLOBULIN POOL

• ACTS AGAINST BACTERIA AND VIRUSES

• OPSONIZING AND NEUTRALIZING

• ACTIVATES COMPLEMENT

• CROSSES PLACENTA

Page 27: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SUBCLASSES OF IgG

• Ig1

• Ig2

• Ig3

• Ig4

• VARY IN COMPOSITION AND NUMBER AND ARRANGEMENT OF DISULFIDE BONDS

Page 28: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULIN M

• ABOUT 10 % OF IMMUNOGLOBULIN POOL

• FOUND ONLY IN SERUM• MONOMERS, PENTAMERS, HEXAMERS• JOINING CHAINS• FIRST ANTIBODY PRODUCED• FOUND ON B CELL MEMBRANES

Page 29: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FUNCTION OF IgM

• FIRST ANTIBODY PRODUCED IN PRIMARY IMMUNE RESPONSE

• AGGLUTINATES• ACTIVATES COMPLEMENT

– BY CLASSICAL PATHWAY

• OPSONIZES• MONOMERIC FORMS ARE FOUND ON

SURFACE OF B LYMPHOCYTES– ACT AS RECEPTORS FOR ANTIGEN

Page 30: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULIN A

• 15 % OF POOL

• MAINLY DIMER IN SERUM

Page 31: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SECRETORY IgA

• SECRETORY IMMUNE SYSTEM• SPECIAL SECRETORY COMPONENT• GI TRACT• RESPIRATORY TRACTS• GENITOURINARY TRACT• SALIVA• TEARS• SWEAT

Page 32: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FUNCTION OF IgA

• PROTECTS BODY SURFACES

• IMMUNE EXCLUSION

• BINDS TO TO ANTIGENS IN LAMINA PROPRIA

• ACTIVATES COMPLEMENT BY ALTERNATIVE PATHWAY

Page 33: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULIN D

• TRACE AMOUNTS IN SERUM

• MAINLY FOUND ON B CELLS

• REGULATES IMMUNE SYSTEM

• MONOMER

• MAY PLAY ROLE IN ELIMINATING SELF-REACTIVE AUTOANTIBODIES

Page 34: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOGLOBULIN E

• LESS THAN 1% OF ANTIBODY

• SKIN SENSITIZING

• ANAPHYLACTIC

• BINDS TO MAST CELLS AND BASOPHILS

• FIGHTS PARASITES

Page 35: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODY DIVERSITY

• REARRANGEMENT OF EXONS

• SOMATIC MUTATIONS

• POST TRANSCRIPTIONAL EDITING

• INDEPENDENT ASSORTMENT OF LIGHT AND HEAVY CHAINS

Page 36: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODY SPECIFICITY

• INFINITE NUMBER OF ANTIBODIES POSSIBLE

• BASED ON B CELL CLONES

Page 37: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CLONAL SELECTION THEORY

• SMALL SET OF CELLS THAT CAN RESPOND TO ANTIGEN

• ALL ARE PRESENT IN FETUS

• ANTIGEN SELECTS THE APPROPRIATE CLONE

• EFFECTOR AND MEMORY CELLS ARE PRODUCED

Page 38: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm
Page 39: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

PRIMARY ANTIBODY RESPONSE

• INITIAL CHALLENGE

• LAG PHASE

• LOG PHASE

• PLATEAU

• PASTEUR PHASE

• LOW ANTIBODY AFFINITY

Page 40: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SECONDARY IMMUNE RESPONSE

• ANAMNESTIC RESPONSE

• PROVIDES IMMUNITY

• CLONES OF B OR T MEMORY CELLS

• SHORTER LOG PHASE

• HIGH ANTIBODY AFFINITY

Page 41: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SPECIAL TYPES OF ANTIBODIES

Page 42: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

POLYCLONAL VS MONOCLONAL ANTIBODIES

http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/

M/Monoclonals.html

Page 43: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNOTOXINS

Page 44: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CHIMERIC MONOCLONAL ANTIBODIES

• PART HUMAN --- PART MOUSE

• VARIABLE REGION—MOUSE

• CONSTANT REGION HUMAN

• 66% HUMAN

• LESS TOXIC

Page 45: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

HUMANIZED ANTIBODIES

• THE ANTIGEN BINDING SITE IS THE ONLY PORTION OF THE ANTIBODY THAT CONTAINS MOUSE PROTEINS

• 90% IS HUMAN

Page 46: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FULLY HUMAN ANTIBODIES

• TRANSGENIC MICE• GENETICALLY MODIFIED MICE

CONTAIN HUMAN ANTIBODY GENES• WOULD PRODUCE FULLY HUMAN

ANTIBODIES• MIGHT BE POSSIBLE TO PRODUCE

THEM TO MATCH THE SPECIFIC PATIENT

Page 47: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CATALYTIC ANTIBODIES

• USED TO TRANSFORM SIMPLE COMPOUNDS– BLOOD CLOTS INHEART

Page 48: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODY FUNCTION

• ACTIVATION OF COMPLEMENT

• TOXIN NEUTRALIZATION

• VIRAL NEUTRALIZATION

• AHERANCE INHIBITION• PARASITIC INFECTIONS

• ANTIBODY DEPENDENT CELL MEDIATED CYTOTOXITY

• OPSONIZATION• REGULATING

INFLAMMATION• IMMUNE COMPLEX

Page 49: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FUNCTION OF COMPLEMENT

• MEDIATE INFLAMMATION

• CHEMOTAXIS

• PHAGOCYTE ACTIVATION

• CYTOLYSIS

• OPZONIZATION

• ACTIVATION OF OTHER IMMUNE CELLS

Page 50: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

COMPLEMENT ACTIVATION

• COMPLEMENT MAKES UP A MAJOR PORTION OF SERUM

Page 51: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ACTIVATORS OF THE ALTERNATE PATHWAY

• MOLECULES WITH REPEATING CHEMICALS STRUCTURES

• ENDOTOXINS

• POLYSACCHARIDES

• LIPOPOLYSACCHARIDES

• TEICHOIC ACID

• Ig A

Page 52: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ACTIVATION BY THE CLASSICAL PATHWAY

• Ig M

• IgG1

• IgG2

• IgG3

• ANTIGEN ANTIBODY COMPLEXES

Page 53: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

COMPLEMENT IS A MAJOR REGULATOR OF THE

INFLAMMATORY RESPONSE

Page 54: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TOXIN NEUTRALIZATION

• BLOCKS ABILITY OF TOXIN TO ENTER CELL OR ATTACH TO CELL RECEPTORS

• ANTIBODIES ARE CALLED ANTITOXINS

Page 55: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

VIRAL NEUTRALIZATION

• IgG

• IgM

• IgA

• BIND TO VIRUSES IN EXTRACELLULAR FLUID AND INACTIVATE THEM

• C4B AIDS IN THIS PROCESS

Page 56: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODIES THAT BLOCK ADHERANCE

• SECRETORY Ig A

• PROTECTS AGAINST PATHOGENS ON MUCOSAL SURFACES

Page 57: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY

• NATURAL KILLER CELLS

• DESTROYS CELLS BY CYTOLYSIS OR BY CYTOTOXIC MEDIATORS

Page 58: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ADDC DEATH BY APOPTOSIS

Page 59: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

APOPTOSIS

Page 60: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ADDC CYTOLYSIS

Page 61: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODIES THAT FIGHT PARASITIC INFECTIONS

• IgE

• EOSINOPHILS ARE INVOLVED ALSO

Page 62: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

OPSONIZATION

• COATING WITH ANTIBODIES• COATING WITH ANTIBODIES AND FIXED

COMPLEMENT• INCREASES PHAGOCYTOSIS OR CAUSES

EXTRACELLUAR DESTRUCTION IF TO BIG FOR PHAGOCYTOSIS

• IgG1• IgM

Page 63: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

OSPSONIZATION AND INTRACELLULAR DESTRUCTION

Page 64: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

OPSONIZATION AND EXTRACELLULAR DESTRUCTION

Page 65: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODIES AND THE INFLAMMATORY RESPONSE

• MAY BE TRIGGERED BY SPECIFIC OR NONSPECIFIC IMMUNE SYSTEM

• IgE ANTIBODIES ON MAST CELLS

• C3a AND C5a OF THE COMPLEMENT SYSTEM

Page 66: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNE COMPLEX FORMATION BY ANTIBODY-

ANTIGEN

• PRECIPITATION

• AGGLUTINATION HEMAGGLUTINATION

Page 67: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANTIBODIES IN THE LAB SETTING

• IN VIVO TESTING

• IN VITRO TESTING

Page 68: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IN VIVO TESTING

• ALLERGY TESTING IMMEDIATE DELAYED (T-CELL)

Page 69: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMEDIATE TESTING

• WITHIN 20 MINUTES

• USED FOR RESPIRATORY ALLERGIES

Page 70: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

DELAYED TESTING• CELL MEDIATED TESTING

• FOOD ALLERGIES

• CONTACT DERMATITIS

• CANDIDA ALBICANS

• TRICHOPHYTON

• MUMPS

• DIPTHERIA-TETANUS TOXOID

• STREPTOKINASE-STREPTODORNASE

• TRICHOPHYTON• MUMPS• DIPTHERIA-TETANUS

TOXOID• STREPTOKINASE-

STREPTODORNASE• TUBERCULIN ANTIGENS• HISTOPLASMA

TUBERCULIN ANTIGENS

Page 71: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T B TESTING

Page 72: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

POSITIVE TB TEST

Page 73: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IN VITRO TESTING

Page 74: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

AGGLUTINATION

• DIRECT AGGLUTINATION WIDAL TEST

• LATEX AGGLUTINATION TEST HUMAN CHORIONIC GONADOTROPIN

• HEMAGLUTINNATION

• ANTIBODY TITER

Page 75: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

COMPLEMENT FIXATION

• WASSERMAN TEST

• VIRAL DISEASES

• FUNGAL DISEASES

• RICKETTSIAL DISEASES

• CHLAMYDIAL DISEASES

• PROTOZOAL DISEASES

Page 76: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ELISA TESTS

• ENZYME LINKED IMMUNOSORBENT ASSAY

• LABELED ENZYMES LINKED TO ANTIGENS OR ANTIBODIES

• HELIOBACTER PYLORI

• SYPHILIS

• BRUCELLOSIS SALMONELLOSIS

• CHOLERA

Page 77: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NEUTRALIZATION REACTIONS

• DETERMINES WHETHER TOXINS OR VIRUSES HAVE BEEN INACTIVATED BY ANTIBODY

• CLOTRIDIUM BOTULINUM

• MANY VIRAL DISEASES

Page 78: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

B CELL BIOLOGY

ANTIGEN SPECIFIC ---T DEPENDENT

POLYCLONAL --- T INDEPENDENT

Page 79: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T DEPENDENT ANTIGEN TRIGGERING

• REQUIRES:ANTIGEN PRESENTING CELLHELPER T CELLB CELL

• MAINLY PROTEINS AND HAPTENS

Page 80: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

B CELLS AND T CELLS ACTIVATE ONE ANOTHER

Page 81: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ALL THE IMMUNE RESPONSES THAT PRODUCE

IgA, IgE AND IgG ARE T DEPENDENT ANTIGEN

TRIGGERED

Page 82: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

B CELL DIFFERENTIATION

• AFFINITY MATURATION

• CLASS SWITCHING

• FORMATION OF PLASMA AND MEMORY CELLS

Page 83: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

AFFINITY MATURATION

• DURING HUMORAL IMUNE RESPONSE AFFINITY OF THE ANTIBODIES TO ANTIGEN INCREASES 100-10,000 TIME

Page 84: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CLASS SWITCHING

• ADDITIONAL REARRANGEMENT OF THEIR HEAVY CHAIN GENE SEGMENTS CAN OCCUR.

• PRODUCES IgG, IgA AND IgE

Page 85: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T INDEPENDENT ANTIGEN TRIGGERING

• NOT ALL ANTIBODY RESPONSES REQUIRE T CELL HELP.

• POLYMERIC

• TUMOR PROMOTING AGENTS

• ANTI-IMMUNOGLOBULIN (ANTI Ig)

• BACTERIAL LIPOPOLYSACCHARIDES

Page 86: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T INDEPENDENT ANTIGEN

• T INDEPENDENT 1

• T INDEPENDENT 2

• GENERALLY WEAKER

• NO MEMORY CELLS FORMED

• IgM PRIMARY ANTIBODY

Page 87: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T INDEPENDENT TYPE 1

• LIPOPOLYSACCHARIDE BACTERIAL CELL WALL COMPONENTS

• MOST ARE MITOGENS--POLYCLONAL

• CAN ACTIVATE UP TO ONE THIRD OF ALL B CELLS WHEN PRESENT AT HIGH LEVELS

Page 88: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T INDEPENDENT TYPE 2

• POLYMERIC MOLECULES

• BACTERIAL CELL WALL POLYSACHARIDES

• POLYMERIC PROTEINS

• DOES NOT REQUIRE DIRECT T HELPER CELL INVOLVEMENT

• REQUIRES T HELPER CYTOKINES FOR CLASS SWITCHING

Page 89: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

DIFFERENCES BETWEEN T DEPENDENT AND

T INDEPENDENT TRIGGERING

T INDEPENDENT IS THE MAIN IMMUNE RESPONSE IN

INFANTS UNTIL AGE TWO

Page 90: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CHEMICAL MEDIATORS OF THE IMMUNE RESPONSE

Page 91: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CYTOKINES

• MEDIATE BOTH SPECIFIC AND NONSPECIFIC IMMUNE RESPONSE

• GENERAL TERM

• PRODUCTS OF ONE CELL POPULATION THAT AFFECTS ANOTHER

Page 92: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TYPES OF CYTOKINES

• MONOKINES

• LYMPHOKINES

• INTERLEUKINS

• CHEMOKINES

Page 93: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FUNCTIONS OF CYTOKINES

• MEDIATE NONSPECIFIC IMMUNITY

• ACTIVATE EFFECTOR CELLS

• MEDIATE MATURE CELL ACTIVATION, DIFFERENTIATION, GROWTH AND BEHAVIOR

• MEDIATE IMMATURE GROWTH AND DIFFERENTIATION

Page 94: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CYTOKINE EFFECTS ON NONSPECIFIC IMMUNITY

• INTERFERON ALPHA

• INTERFERON BETA

Page 95: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERFERON ALPHA

• PRODUCED BY MACROPHAGES AND MONOCYTES

• INDUCES THE ANTIVIRAL STATE• INCREASES EXPRESSION OF CLASS I

MHC MARKERS ON MACROPHAGES• INCREASES EXPRESSION OF Fc

RECEPTORS ON MACROPHAGES• ACTIVATES NATURAL KILLER CELLS

Page 96: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERFERON BETA• PRODUCED BY FIBROBLASTS INDUCES

ANTIVIRAL STATE• MODULATES ANTIBODY PRODUCTION• INDUCES DIFFERENTIATION OF FIBROBLASTS• STIMULATES EXPRESSION OF MHC MARKERS• ENHANCES SECRETION OF INTERLEUKIN 1

alpha AND TUMOR NECROSIS FACTOR BY MACROPHAGES

Page 97: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERLEUKIN 1

• MEDIATES BOTH SPECIFIC AND NONSPECIFIC IMMUNITY

• PRODUCED BY A VARIETY OF CELLS• STIMULATES T HELPER CELLS

INPRESENCE OF ANTIGEN• ATTRACTS PHAGOCYTES IN

INFLAMMATORY RESPONSE• STIMULATES HYPOTHALAMUS AND

CAUSES FEVER– ENDOGENOUS PYROGEN

Page 98: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CHEMOKINES

• PARACRINE

• LOW WEIGHT MOLECULES

• MEDIATES INFLAMMATORY RESPONSE

• INDUCES MIGRATION OF WHICHT BLOOD CELLS INTO INFECTED OR DAMAGED AREAS

Page 99: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TUMOR NECROSIS FACTOR ALPHA

• ONE OF THE MAJOR CYTOKINES THAT MEDIATES THE HOST RESPONSE TO GRAM NEGATIVE BACTERIA

• RELEASED BY MONONUCLEAR PHAGOCYTES – DUE TO STIMULATION OF

LIPOPOLYSACCHARIDE

Page 100: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ACTIONS OF TUMOR NECROSIS FACTOR ALPHA

• STIMULATES AN INCREASE IN B CELLS• INITIATES LEUKOCYTE ADHERANCE TO

VASCULAR ENDOTHELIUM• STIMULATES OTHER MONONUCLEAR

PHAGOCYTES TO SECRETE INTERLEUKINS 1, 6 OR 8

• STIMULATES THE HYPOTHALMUS TO INDUCE FEVER– ACTS AS AN ENDOGENOUS PYROGEN

• IS CYTOTOXIC TO TUMOR CELLS

Page 101: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TUMOR NECROSIS CHEMOKINES AND INTERLEUKIN 1 ROLE IN

EXTRAVASATION

Page 102: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERFERON GAMMA

• PRODUCED BY – T HELPER CELLS, CYTOTOXIC CELLS AND NATURAL

KILLER CELLS• AMPLIFIES ACTIVATION OF T HELPER CELLS• INCREASES THE EXPRESSION OF MHC MOLECULES• PROMOTES DIFFERENTIATION OF BOTH T AND B

CELLS• REGULATES THE RELEASE OF Ig FROM CELLS• PROMOTES MATURATION OF CYTOTOXIC T CELLS• INDUCES ANTIVIRAL STATE• ACTIVATES MACROPHAGES, NEUTROPHILS AND

NATURAL KILLER CELLS

Page 103: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

MIGRATION INHIBITION FACTOR

• PRODUCED BY MACROPHAGES

• ACTIVATES MACROPHAGES

• PREVENTS MIGRATION FROM SITE

• SECRETION INDUCED BY TUMOR NECROSIS FACTOR, LIPOPOLYSACCHARIDES AND OTHER FACTORS

Page 104: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERLEUKIN 2

• PRODUCED BY HELPER T CELLS– FOR SHORT PERIOD AFTER ACTIVATION BY ANTIGEN

• MEDIATES THE ACTIVATION, GROWTH AND DIFFERENTIATION OF MATURE LYMPHOCYTES

• TRIGGERS THE POLIFERATION OF T HELPER AND CYTOTOXIC T CELLS

• CAN INDUCE THE SYNTHESIS OF INTERFERON– INDIRECTLY ACTIVATES NATURAL KILLER CELLS

• STIMULATES THE GROWTH OF CERTAIN B CELLS• HAS BEEN USED AGAINST CERTAIN CANCERS

– RENAL CELL CARCINOMA– MALIGNANT MELANOMA

Page 105: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERLEUKIN 3

• COLONY STIMULATING FACTOR

• STIMULATES PROLIFERATION OF STEM CELLS IN BONE MARROW

• INFLUENCES DIFFERENTIATION OF BONE MARROW CELLS– MAST CELLS, MACROPHAGES AND

GRANULOCYTES

Page 106: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERLEUKIN 8

• CHEMOATTRACTANT FOR PHAGOCYTES AND OTHER IMMUNE CELLS TO SITE OF INFLAMMATION

• ALSO CALLED NEUTROPHIL ACTIVATING FACTOR

• SECRETED BY A VARIETY OF CELLS• CONSIDERED A CHEMOKINE• PRIMARILY MEDIATE THE ACTIVATION

AND MIGRATION OF NEUTROPHILS INTO THE TISSUES FROM BLOOD STREAM

Page 107: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERLEUKIN 10

• SECRETED BY T HELPER 2 CELLS AND T REGULATOR CELLS

• INTERFERS WITH THE ACTIVATION OF T HELPER 1 CELLS

• INHIBITS CYTOKINE PRODUCTIN BY MACROPHAGES

• MAINLY PLAYS AN ANTI-INFLAMMATOR ROLE

Page 108: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERLEUKIN 12

• INVOLVED IN THE DIFFERENTIATION OF T HELPER CELLS– T HELPER 1 REPONSE

• ENHANCES CYTOTOXIC ACTIVITY OF NATURAL KILLER CELLS AND CYTOTOXIC T LYMPHOCYTES

• BLOCKS THE FORMATION OF NEW BLOOD VESSELS BY INDUCING THE PRODUCTION OF INTERFERON GAMMA

Page 109: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T CELL BIOLOGY

RESPOND TO MHC MARKERS

Page 110: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

MHC MOLECULES

• FOUND ON ALL NUCLEATED CELLS• ALSO CALLED HUMAN LEUKOCYTE

ANTIGENS (HLAs)• CLASS I• CLASS II• CLASS III

– ASSOCIATED WITH COMPLEMENT SYSTEM

Page 111: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CLASS I & II MHC STRUCTURE

• TWO PROTEIN CHAIN

• GROOVE INTO WHICH PEPTIDE MOLECULES CAN BE INSERTED– WHICH MAY OF MAY NOT CAUSE A

IMMUNE RESPONSE

Page 112: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SOURCES OF MHC CLASS I & II

ANTIGEN PROCESSING

ENDOGENOUS VS EXOGENOUS

Page 113: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CLASS I MHC MOLECULES

• ENDOGENOUS ANTIGENS• PEPTIDES THAT ORIGINATE IN THE

CYTOSOL• PEPTIDES AND MHC CLASS I COMBINE • CARRIED TO PLASMA MEMBRANE • DISPLAYED TO PASSING CD 8+ CELLS

Page 114: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CELLS ARE CONSTANTLY TAKING INVENTORY OF ITS CELLULAR

PRODUCTS

• PROTEOSOMES CHOP OF VARIOUS PROTEINS IN CELL INTO PEPTIDE EPITOPES– SERIES OF PEPTIDES– APPROIMATELY 8-10 AMINO ACIDS

LONG

Page 115: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

EXAMPLES OF ENDOGENOUS ANTIGENS

• PRODUCED WITHIN CELLS OF THE BODY. – VIRAL PROTEINS PRODUCED DURING VIRAL

REPLICATION– PROTEINS PRODUCED BY INTRACELLULAR

BACTERIA SUCH AS RICKETTSIAS AND CHLAMYDIAS DURING THEIR REPLICATION

– PROTEINS THAT HAVE ESCAPED INTO THE CYTOSOL FROM THE PHAGOSOME OF PHAGOCYTES SUCH AS ANTIGEN-PRESENTING CELLS

– TUMOR ANTIGENS PRODUCED BY CANCER CELLS– SELF PEPTIDES FROM HUMAN CELL PROTEINS.

Page 116: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

PROTEINS THAT HAVE ESCAPED INTO THE CYTOSOL FROM THE PHAGOSOME OF PHAGOCYTES SUCH AS ANTIGEN-

PRESENTING CELLS

Page 117: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CLASS II MHC MOLECULES

• EXOGENOUS ANTIGEN

• BROUGHT INTO ANTIGEN PRESENTING CELL BY ENDOCYTOSIS

• DIGEST IN PHAGOLYSOSOME

• FRAGMENTS COMBINE WITH PREFORMED MHC CLASS II

• DISPLAYED ON PLASMA MEMBRANE

• RECOGNIZED BY CD4 + CELLS

Page 118: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FORMATION OF MHC CLASS II

• EXAMPLES – BACTERIA– FREE VIRUSSE– YEASTS – PROTOZOA– TOINS

Page 119: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CLASSES OF MHC MOLECULES

• A, B, C, AND D

• CLASS I--A, B AND C

• CLASS II-- D GROUP

• MHC MOLECULES ARE ALSO INVOLVED IN SUSCEPTIBILITY T PARTICULAR INFECTIOUS AND NONINFECTIOUS DISEASES

Page 120: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T CELLS

• SECRETE CYTOKINES

• ATTACK VIRUS INFECTED CELLS

• ATTACK HOST CELLS WITH INTRACELLULAR PARASITES

• ATTACK CANCER CELLS

• CELL MEDIATED IMMUNITY

Page 121: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T CELLS

• MADE IMMUNOCOMPETENT IN FETAL THYMUS

• FOUND IN BLOOD AND LYMPH SYSTEM

Page 122: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TYPES OF T CELLS

T HELPER, CTYOTOXIC T CELLS

AND REGULATOR

Page 123: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CD 4 T HELPER CELLS

• DO NOT DIRECTLY KILL THE CELL• CAN ENLARGE AND DIVIDE

– INCREASES NUMBER OF T4 CELLS

• CAN SECRETE CYTOKINES – INHIBITS PATHOGEN– RECRUIT OTHER CELLS

• T HELPER 1, T HELPER 2 AND T HELPER 0

Page 124: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T HELPER CELLS

• Th 1– RECOGNIZE ANTIGEN PRESENTED BY

MACROPHAGES – INITIATE CELL MEDIATED IMMUNITY– PRODUCE IL-2, INTERFERON GAMMA,

LYMPHOTOXIN, AND TUMOR NECOSIS FACTOR BETA

• PROLIFERATION OF T 8 LYMPHOCYTES• DIFFERENTIATION INTO CYTOTOXIC T

LYMPHOCYTES• ACTIVATION OF CYTOTOXIC T LYMPHOCYTES• ACTIVATION OF NATURAL KILLER CELLS• PROLIFERATION OF T 4 LYMPHOCYTES

Page 125: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T HELPER CELLS

• T HELPER 2• RESPOND TO ANTIGENS PRESENTED BY B

LYMPHOCYTES (AS ANTIGEN PRESENTING CELLS)

• PRODUCE INTERLEUKINS 2, 4, 5, 10 AND 13– STIMULATE ANTIBODY PRODUCTION– STIMULATE DIFFERENTIATION INTO PLASMA CELLS– ENABLE – CLASS SWITCHING– ACTIVATE EOSINOPHILS AND INCREASE IgE

• TO FIGHT HELMINTHS AND ARTHROPODS

Page 126: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T HELPER CELLS

• BALANCE BETWEEN T HELPER 1 AND T HELPER 2 PLAYS A ROLE IN HOW WELL THE CELL FIGHTS CERTAIN INFECTIONS

Page 127: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T REGULATOR CELLS

• FORMERLY KNOWN AS SUPPRESSOR T CELLS

• MAY OR MAY NOT EXIST

• THEIR FUNCTION IS TO SUPRESS THE ACTIVITY OF OTHER T CELLS

Page 128: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ACTIVATION OF T HELPER CELLS

• NEED ANTIGEN PRESENTING CELLS DISPLAYING TYPE II MHC MARKERS

• T HELPER CELLS ARE CLASS II RESTRICTED– ONLY INTERACT WITH CELLS PRESENTING

CLASS MHC II MOLECULES• B CELLS, DENDRITIC CELLS, AND MACROPHAGES

Page 129: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANIMATION OF T 4 HELPER CELLS ACTIVATION

Page 130: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANIMATION OF THE EFFECTS OF INTERLEUKIN 2

Page 131: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ACTIVATION OF CYTOTOXIC T CELLS

• NEED ANTIGEN PRESENTING CELLS DISPLAYING TYPE I MHC MARKERS– CD8 CYTOTOXIC CELLS ARE CLASS I

RESTRICTED• ONLY RESPOND TO CLASS I MHC MARKERS

Page 132: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANIMATION OF CD8 CYTOTOXIC T CELL ACTIVATION

• COMBINATION OF T CELL RECEPTOR AND CD8 MARKERS WITH MHC CLASS I MARKERS ON MACROPHAGE ACTIVATE CYTOTOXIC T CELL AND LEADS TO ITS DIFFERENTIATION INTO A CYTOTOXIC T LYMPHOCYTE

Page 133: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

EFFECTS OF INTERLEUKIN 2 SECRETED BY HELPER T CELLS ON ACTIVATED CYTOTOXIC T CELLS

• ONCE ACTIVATED SIGNALS AND CYTOKINES FROM T HELPER 1 CELLS WILL LEAD TO PROLIFERATION OF CD8 CELLS AND THEIR DIFFERENTIATION INTO CYTOTOXIC T LYMPHOCYTES

• CYTOTOXIC T CELLS DO NOT DISPLAY INTERLEUKIN 2 RECEPTORS UNTIL THEY ARE ACTIVATED– ONLY CYTOTOXIC T LYMPHOCYTES CAN KILL

OTHER CELLS• NIAVE CYTOTOXIC T CELLS CANNOT

Page 134: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm
Page 135: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANIMATION OF ACTIVATED CYTOXIC T CELL PROLIFERATION

Page 136: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ANIMATION OF DIFFERENTIATION INTO CYTOTOXIC T LYMPHOCYTES

Page 137: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

• THEY ONLY BIND TO THOSE CELLS THAT DISPLAY A MHC CLASS I MARKER WITH THE SAME ANTIGEN THEY ARE SPECIFIC FOR

• THEY BIND TO THE MHC CLASS I MARKER AND RELEASE PERFORIN, GRANZYMES AND CHEMOKINES THAT TRIGGER EITHER LYSIS OR APOPTOSIS

CYTOTOXIC T LYMPHOCYTES THEN TRAVEL THROUGHOUT THE BODY

BINDING TO INFECTED CELLS

Page 138: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

APOPTOSIS

Page 139: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

OTHER ACTIVITIES OF T HELPER CELLS

Page 140: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T HELPER 1 CELLS ALSO ACTIVATE MACROPHAGES

• BINDING OF MACROPHAGE TO T HELPER 1 CAUSES SECRETION INTERFERON GAMMA BY T HELPER 1 CELLS

• INTERFERON BINDS TO RECEPTORS ON MACROPHAGE

• INTERFERON GAMMA ACTIVATES MACROPHAGE– PRODUCES MORE HYDROLYTIC ENZYMES IN

LYSOSOME– PRODUCES MORE NITIC OXID– PRODUCES MORE TOXIC OXYGEN RADICALS

Page 141: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

T HELPER CELLS ALSO ACTIVATE NATURAL KILLER CELLS

• IL-2 AND IFN GAMMA PRODUCED BY T helper 1 CELLS ACTIVATE NATURAL KILLER CELLS

Page 142: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

AQUIRED IMMUNE TOLERANCE

• TOLERANCE INDUCTION

• BODY’S ABILITY TO MAKE ANTIBODIES AGAINST NONSELF ANTIGENS WHILE TOLERATING SELF ANTIGENS

• ESTABLISHED EARLY IN EMBRYONIC LIFE

Page 143: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NULL CELLS

• LACK SPECIFIC SURFACE MARKERS

• NATURAL KILLER CELLS

• PART OF NOSPECIFIC IMMMITY

Page 144: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NATURAL KILLER CELLS

• SMALL POPULATION

• NONSPECIFIC

• NULL CELLS

• DESTROY TUMORS

• VIRUS INFECTE CELLS

• FUNGI, BACTERI, PROTOZOA, AND HELMINTHS

• IMMUNE SURVEILLANCE

Page 145: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

HOW NATURAL KILLER CELLS WORK

• ACTIVATED BY INTERFERONS AND INTERLEUKIN 2

• CALCIUM DEPENDENT SEQUENCE

• INSERT PERFORIN 1 INTO TARGET

• RELEASE LYSOSOMAL SECRETIONS– CAUSES LYSIS OR APOPTOSIS

Page 146: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERACTION OF A NATURAL KILLER CELL WITH A NORMAL

BODY CELL

Page 147: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

INTERACTION OF A NATURAL KILLER CELL WITH A CELL NOT

DISPLAYING MHC CLASS I MARKERS

Page 148: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

APOPTOSIS

• PROGRAMED CELLULAR DEATH

Page 149: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

NATURAL KILLER CELLS INTERACTIONS ARE PART OF

NONSPECIFIC IMMUNITY

Page 150: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SUPERANTIGENS

• BACTERIAL PROTEINS

• STIMULATE IMMUNES SYSTEM MORE EXTENSIVELY

• NONSPECIFICALLY STIMULATE T CELLS

Page 151: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

• INDUCE MASSIVE CYTOKINE PRODUCTION

Page 152: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

HYPERSENSITIVITIES

• ALLERGIES

• EXAGGERATED IMMUNE RESPONSE

• IMMEDIATE OR DELAYED

• MAIN DIFFERENCE IN HOW IMMUNE SYSTEM RESPONDS

Page 153: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TYPE I ANAPHYLACTIC HYPERSENSITIVITY

• IgE ANTIBODY• MAY BE HEREDITARY DISPOSITION• IgE BINDS TO BASOPHIL AND MAST

CELLS• T DEPENDENT IMMUNITY• SUBSEQUENT EXPOSURE WILL CAUSE

MAST CELLS AND BASOPHILS TO DEGRANULATE

Page 154: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SYSTEMIC ANAPHYLAXIS

• LARGE MAST CELL DEGRANULATION IN SHORT TIME

• SMOOTH MUSCLE CONSTRICTION IN BRONCHIOLES

• ARTERIOLE DILATION

• INCREASED VASCULAR PERMEABILITY

Page 155: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CAUSE OF DEATH

• REDUCED VENOUS RETURN

• REDUCED BLOOD PRESSURE

• CIRCULATORY SHOCK

• ASPHYXIATION

Page 156: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

POSSIBLE CAUSES

• DRUGS

• ANTISERA

• INSECT VENOM

Page 157: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

LOCALIZED ANAPHYLAXIS

• ATOPIC

• ALLERGIC RHINITIS

• BRONCHIAL ASTHMA

• FOOD ALLERGIES

Page 158: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

PREVENTING TYPE I RESPONSES

• REPLACE IgE RESPONSE WITH IgG RESPONSE

• SERIES OF ALLERGEN SHOTES

• EFFECTIVE ABOUT 65 TO 75% WITH INHALED ALLERGENS

Page 159: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TYPE II CYTOTOXIC HYPERSENSITIVITIES

• DESTRUCTION OF HOST CELLS

• LYSIS OR TOXIC MEDIATORS

• ANTIBODY MEDIATED CELL-MEDIATED CYTOTOXICITY

• IgG OR IgM

• DIRECTED AGAINST TISSUES OR CELL SURFACES

• INTERACT WITH COMPLEMENT

Page 160: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

EXAMPLES

• BLOOD TRANSFUSIONS WITH WRONG BLOOD TYPE (ABO)

• HEMOLYTIC DISEASE OF THE NEWBORN

• DRUG INDUCED HEMOLYTIC ANEMIA

Page 161: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

DRUGS THAT CAN INTIATE A TYPE II HYPERSENSITIVITY

• PENICILLIN

• QUINIDINE

• METHYLDOPA

Page 162: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TYPE III IMMUNE COMPLEX HYPERSENSITIVITY

• FORMATION OF IMMUNE COMPLEXES

• NORMALLY REMOVED BY RETICULOENDOTHELIAL SYSTEM

• EXCESS MAY ACCUMULATE

• ACTIVATES COMPLEMENT

Page 163: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

EXAMPLES OF TYPE III HYPERSENSITIVITIES

• SERUM SICKNESS

• DRUG REACTIONS

• POSTSTREPTOCOCCAL GLOMERULONEPHRITIS

• SYSTEMIC LUPUS ERYTHEMATOSUS

• RHEUMATOID ARTHRITIS

• GOODPASTURE’S SYNDROME

• FARMERS LUNG

Page 164: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

ASPERGILLOSIS

Page 165: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

GLOMERULAR NEPHRITIS

Page 166: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TYPE IV CELL MEDIATED HYPERSENSITIVITY

• T CELL MEDIATED

• USUALLY TAKES DAYS TO OCCUR

• MEDIATED BY CYTOKINES

• CAUSES EXTENSIVE TISSUE DAMAGE

Page 167: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

EXAMPLES OF TYPE IV

• INTRACELLULAR PARASITE MYCOBACTERIUM

• TB TEST

• SOME AUTOIMMUNE DISEASE

• CONTACT DERMATITIS

• KILLING OF CANCER CELLS

• TRANSPLANT REJECTION

Page 168: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

AUTOIMMUNE DISORDERS

• FAILURE TO RECOGNIZE SELF ANTIGENS

Page 169: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

AUTOIMMUNITY VS AUTOIMMUNE DISORDER

Page 170: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

FACTORS THAT AFFECT AUTOIMMUNE DISORDERS

• VIRUSES

• GENETICS

• ENDOCRINE SYSTEM

• PSYCHONEUROIMMUNOLOGICAL

Page 171: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

MORE COMMON IN OLDER PEOPLE

Page 172: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

TRANSPLANT REJECTION

• ISOGRAFTS

• ALLOGRAFTS

• XENOGRAFTS

Page 173: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

MECHANISMS OF TISSUE REJECTION

• T CELL IMMUNITY IS ACTIVATED

• CYTOTOXIC T CELLS KILL TISSUES

• T HELPER CELLS RELEASE CYTOKINES

• NATURAL KILLER CELLS ALSO INVOLVED

Page 174: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMPORTANCE OF MHC MARKERS

• CLASS I MHC MARKERS

• 77 MHC MOLECULES CODED FOR BY FOUR GENES

• ATTEMPT TO MAKE AS CLOSE A MATCH AS POSSIBLE

Page 175: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CYCLOSPORIN. TACROLIMUS AND OTHER

DRUGS GIVEN TO SUPPRESS T CELL IMMUNITY

Page 176: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

IMMUNODEFICIENCIES

PRIMARY/CONGENITAL

VS

SECONDARY/ACQUIRED

Page 177: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

PRIMARY/CONGENITAL IMMUNODEFICIENCY

• CHRONIC GRANULOMATUS DISEASE

• COMMON VARIABLE HYPOGAMMOGLOBULEREMIA

• DI GEORGE’S SYNDROME

• SEVERE COMBINE IMMUNODEFICIENCY DISEASE

Page 178: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

CHRONIC GRANULOMATOSUS DISEASE

• RECURRENT INFECTIONS• DEVELOPMENT OF INFLAMMATORY

CELLS – IN LYMPH NODES, LUNGS, BONES AND SKIN

• INHERITED LACK OF NADPH OXIDASE IN NEUTROPHILS– THEY ARE UNABLE TO KILL INGESTED

MICROBES

Page 179: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

Di GEORGE’S SYNDROME

• THYMUS FAILS TO DEVELOP

• NO T CELL IMMUNITY– CELL MEDIATED– T DEPENDENT HUMORAL IMMUNITY

• GENERALLY DIE OF VIRAL INFECTION

Page 180: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

BRUTON-TYPE AGAMMAGLOBULEMAI

• INHERITED DEFECT USUALLY INHERITED BY BOYS

• CANNOT MAKE ANTIBODIES• SUFFER RECURRENT BACTERIAL

INFECTIONS• DO HAVE CELL MEDIATED IMMUNITY • IMMUNOGLOBULIN DEFICIENCIES

USUALLY OCCUR IN ONLY ONE Ig CLASS– IgA IS MOST COMMON

Page 181: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SEVERE COMBINED IMMUNODEFICIENCY DISEASE

• SCIDs

• NEITHER B OR T CELLS ARE PRODUCED

• BOY IN THE BUBBLE

Page 182: IMMUNITY THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC   /toc.htm

SECONDARY IMMUNODEFICIENCIES

• ACQUIRED AFTER BIRTH

• CANCER

• STRESS

• DIABETES

• MALNUTRITION

• CERTAIN ENVIRONMENTAL TOXINS

• HIV